BK0046
0.00
+0.00
--
最高
0.00
最低
0.00
成交量
0.00
今开
0.00
昨收
0.00
日振幅
0.00%
总市值
0.00
流通市值
0.00
总股本
0.00
成交额
0.00
换手率
--
流通股本
0.00
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
迈克生物最新公告:公司新产品取得产品注册证书
证券之星 · 16:55
迈克生物最新公告:公司新产品取得产品注册证书
迈克生物(300463.SZ)取得一项医疗器械注册证
智通财经 · 16:29
迈克生物(300463.SZ)取得一项医疗器械注册证
北陆药业(300016)9月18日主力资金净卖出954.13万元
证券之星 · 15:26
北陆药业(300016)9月18日主力资金净卖出954.13万元
开能健康(300272)9月18日主力资金净卖出638.53万元
证券之星 · 15:25
开能健康(300272)9月18日主力资金净卖出638.53万元
南华生物(000504)9月18日主力资金净卖出990.87万元
证券之星 · 15:23
南华生物(000504)9月18日主力资金净卖出990.87万元
安图生物09月18日遭主力抛售819万元 环比增加680.00%
市场透视 · 15:19
安图生物09月18日遭主力抛售819万元 环比增加680.00%
A股医疗器械板块盘初走低,英科医疗、阳普医疗双双跌停,冠昊生物、中红医疗、华大智造、利德曼等跌幅居前。
美港电讯 · 09:34
A股医疗器械板块盘初走低,英科医疗、阳普医疗双双跌停,冠昊生物、中红医疗、华大智造、利德曼等跌幅居前。
岳阳兴长(000819)9月13日主力资金净卖出2293.57万元
证券之星 · 09:24
岳阳兴长(000819)9月13日主力资金净卖出2293.57万元
以岭药业获得发明专利授权:“一种含麻黄的抗菌抗病毒中药组合物及其制备方法和应用”
证券之星 · 02:11
以岭药业获得发明专利授权:“一种含麻黄的抗菌抗病毒中药组合物及其制备方法和应用”
左手瘦身右手并购 海利生物收函
媒体滚动 · 00:00
左手瘦身右手并购 海利生物收函
以岭药业:参松养心科研成果重磅发表,彰显中医药智慧
证券之星 · 09-17 19:22
以岭药业:参松养心科研成果重磅发表,彰显中医药智慧
以岭药业:带头发展中药现代化,科技赋能传统医学
证券之星 · 09-17 19:22
以岭药业:带头发展中药现代化,科技赋能传统医学
科华生物新提交2件商标注册申请
证券之星 · 09-17 13:34
科华生物新提交2件商标注册申请
【机构调研记录】国联安基金调研乐鑫科技、上海莱士
证券之星 · 09-16 08:01
【机构调研记录】国联安基金调研乐鑫科技、上海莱士
鲁抗医药新提交1件商标注册申请
证券之星 · 09-15
鲁抗医药新提交1件商标注册申请
达安基因:市场对分子诊断试剂的需求量在增加
美港电讯 · 09-15
达安基因:市场对分子诊断试剂的需求量在增加
达安基因:9月13日接受机构调研,国海证券、广东凯鼎投资等多家机构参与
证券之星 · 09-14
达安基因:9月13日接受机构调研,国海证券、广东凯鼎投资等多家机构参与
天坛生物(600161)9月13日主力资金净卖出6911.55万元
证券之星 · 09-14
天坛生物(600161)9月13日主力资金净卖出6911.55万元
健友股份:融资余额6670.15万元,创近一年新低(09-13)
东方财富 · 09-14
健友股份:融资余额6670.15万元,创近一年新低(09-13)
上海莱士:有知名机构正心谷资本,高毅资产参与的多家机构于9月13日调研我司
证券之星 · 09-14
上海莱士:有知名机构正心谷资本,高毅资产参与的多家机构于9月13日调研我司
暂无数据
{"stockData":{"symbol":"BK0046","market":"CN","secType":"PLATE","latestPrice":0,"timestamp":0,"preClose":0,"halted":0,"volume":0,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatusCode":0,"change":0,"open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"adr":0,"adjPreClose":0},"requestUrl":"/m/hq/s/BK0046/tweets","defaultTab":"tweets","newsList":[{"id":"2468972370","title":"迈克生物最新公告:公司新产品取得产品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2468972370","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468972370?lang=zh_cn&edition=full","pubTime":"2024-09-18 16:55","pubTimestamp":1726649708,"startTime":"0","endTime":"0","summary":"迈克生物公告,公司近日收到四川省药品监督管理局颁发的《医疗器械注册证(体外诊断试剂)》,产品为纤溶酶原活性测定试剂盒(发色底物法),主要用于评估纤溶功能状态。该产品的注册证取得进一步丰富了公司产品项目菜单,有助于提升公司市场综合竞争力,对市场的拓展以及公司未来的经营将产生积极影响。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091800023839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","300463","BK0028","BK0239","BK0046"],"gpt_icon":0},{"id":"2468725813","title":"迈克生物(300463.SZ)取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2468725813","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468725813?lang=zh_cn&edition=full","pubTime":"2024-09-18 16:29","pubTimestamp":1726648145,"startTime":"0","endTime":"0","summary":"智通财经APP讯,迈克生物(300463.SZ)公告,公司近日收到四川省药品监督管理局颁发的《医疗器械注册证(体外诊断试剂)》,产品名称为:纤溶酶原活性测定试剂盒(发色底物法)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1184079.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","300463","BK1574","BK0239","BK0012","09996","159883","BK0028","BK1222","BK0046","09997","BK1100"],"gpt_icon":0},{"id":"2468376337","title":"北陆药业(300016)9月18日主力资金净卖出954.13万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468376337","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468376337?lang=zh_cn&edition=full","pubTime":"2024-09-18 15:26","pubTimestamp":1726644382,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年9月18日收盘,北陆药业报收于4.86元,下跌3.57%,换手率3.26%,成交量16.01万手,成交额7786.14万元。9月18日的资金流向数据方面,主力资金净流出954.13万元,占总成交额12.25%,游资资金净流入209.09万元,占总成交额2.69%,散户资金净流入745.03万元,占总成交额9.57%。北陆药业主营业务:对比剂制剂及原料药、中枢神经类和降糖类药品的研发、生产与销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091800016608.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300016","BK0239","BK0060","BK0042","BK0046"],"gpt_icon":0},{"id":"2468376353","title":"开能健康(300272)9月18日主力资金净卖出638.53万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468376353","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468376353?lang=zh_cn&edition=full","pubTime":"2024-09-18 15:25","pubTimestamp":1726644334,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年9月18日收盘,开能健康报收于4.95元,下跌3.88%,换手率4.88%,成交量21.03万手,成交额1.05亿元。9月18日的资金流向数据方面,主力资金净流出638.53万元,占总成交额6.11%,游资资金净流入203.91万元,占总成交额1.95%,散户资金净流入434.61万元,占总成交额4.16%。开能健康主营业务:全屋净水机、全屋软水机、商用净化饮水机、RO膜反渗透净水机、多路控制阀、复合材料压力容器等人居水处理产品的研发、制造、销售与服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091800016574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0224","BK0135","300272","BK0150","BK0020","BK0046"],"gpt_icon":0},{"id":"2468376307","title":"南华生物(000504)9月18日主力资金净卖出990.87万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468376307","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468376307?lang=zh_cn&edition=full","pubTime":"2024-09-18 15:23","pubTimestamp":1726644236,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年9月18日收盘,南华生物报收于6.97元,下跌4.39%,换手率4.1%,成交量12.74万手,成交额8883.98万元。南华生物主营业务:主要从事干细胞、免疫细胞等人类生物资源储存、细胞生物技术研发、细胞治疗技术的临床应用研究等细胞医疗服务,同时也是节能环保综合解决方案提供商。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091800016532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0042","000504","BK0282","BK0086"],"gpt_icon":0},{"id":"2468379233","title":"安图生物09月18日遭主力抛售819万元 环比增加680.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468379233","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468379233?lang=zh_cn&edition=full","pubTime":"2024-09-18 15:19","pubTimestamp":1726643951,"startTime":"0","endTime":"0","summary":"09月18日, 安图生物股价跌0.44%,报收38.19元,成交金额7968万元,换手率0.36%,振幅2.45%,量比1.01。安图生物今日主力资金净流出819万元,上一交易日主力净流出105万元,今日环比增加680.00%。该股近5个交易日下跌3.95%,主力资金累计净流出1144万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入1095万元,其中净流入天数为8日。该股主力净额占比0.04%,A股市场排名3401/5000,低于行业平均值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409181534379f04690f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409181534379f04690f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603658","BK0239","BK0046"],"gpt_icon":0},{"id":"2468141345","title":"A股医疗器械板块盘初走低,英科医疗、阳普医疗双双跌停,冠昊生物、中红医疗、华大智造、利德曼等跌幅居前。","url":"https://stock-news.laohu8.com/highlight/detail?id=2468141345","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468141345?lang=zh_cn&edition=full","pubTime":"2024-09-18 09:34","pubTimestamp":1726623267,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0042","159883","09996","BK0146","BK1583","159982","BK0239","BK1100","300030","300238","BK0251","BK1222","BK0028","09997","BK0220","BK0086","399300","300289","BK0046","BK1574","300677","688114","300981","BK0077"],"gpt_icon":0},{"id":"2468345698","title":"岳阳兴长(000819)9月13日主力资金净卖出2293.57万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468345698","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468345698?lang=zh_cn&edition=full","pubTime":"2024-09-18 09:24","pubTimestamp":1726622650,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年9月13日收盘,岳阳兴长报收于15.2元,下跌3.74%,换手率1.65%,成交量5.74万手,成交额8798.92万元。近5日资金流向一览见下表:岳阳兴长融资融券信息显示,融资方面,当日融资买入582.25万元,融资偿还874.08万元,融资净偿还291.83万元。岳阳兴长主营业务:从事石油化工产品的开发、生产、销售以及成品油零售等业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091800004445.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000819","BK0010","BK0275","BK0046","BK0199"],"gpt_icon":0},{"id":"2468398033","title":"以岭药业获得发明专利授权:“一种含麻黄的抗菌抗病毒中药组合物及其制备方法和应用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2468398033","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468398033?lang=zh_cn&edition=full","pubTime":"2024-09-18 02:11","pubTimestamp":1726596691,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示以岭药业新获得一项发明专利授权,专利名为“一种含麻黄的抗菌抗病毒中药组合物及其制备方法和应用”,专利申请号为CN202011044323.2,授权日为2024年9月17日。动物试验、抑菌试验证明,该抗菌抗病毒中药组合物还具有显著的抗病毒、抗菌和退热的作用,故可用于制备治疗以上症状的药物以及抗病毒、抗菌药物。今年以来以岭药业新获得专利授权11个,较去年同期减少了26.67%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091800000692.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0097","BK0239","BK0046","BK0188","002603"],"gpt_icon":0},{"id":"2468314802","title":"左手瘦身右手并购 海利生物收函","url":"https://stock-news.laohu8.com/highlight/detail?id=2468314802","media":"媒体滚动","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468314802?lang=zh_cn&edition=full","pubTime":"2024-09-18 00:00","pubTimestamp":1726588800,"startTime":"0","endTime":"0","summary":" 在业绩下滑的背景下,海利生物抛出了重组计划,拟进行重大资产购买及重大资产出售,一方面进军口腔修复业务,一方面剥离难以控制经营决策的相关资产。这一重组事项遭到了上交所关注,公司于近日收到了上交所下发的问询函。 资料显示,海利生物是一家主营人用体外诊断试剂以及动物生物制品的企业,瑞盛生物主营口腔组织修复与再生材料。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-09-18/doc-incpnwhy5611264.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-09-18/doc-incpnwhy5611264.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0070","603718","BK0239","BK0046"],"gpt_icon":0},{"id":"2468355090","title":"以岭药业:参松养心科研成果重磅发表,彰显中医药智慧","url":"https://stock-news.laohu8.com/highlight/detail?id=2468355090","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468355090?lang=zh_cn&edition=full","pubTime":"2024-09-17 19:22","pubTimestamp":1726572167,"startTime":"0","endTime":"0","summary":"《欧洲心脏杂志》作为全球心血管研究的顶级平台,对参松养心胶囊的研究成果的录用,无疑是对这一创新中药疗法的全球认可。参松养心胶囊的这一研究成果,以其显著的临床效果和坚实的科学依据,为全球的心律失常患者带来了新的治疗希望。未来,以岭药业将继续秉承科学、严谨的研究态度,不断探索中医药的无限可能,为全球健康事业贡献更多力量。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://news.stockstar.com/IG2024091700006253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0097","BK0046","BK0239","002603","BK0042"],"gpt_icon":0},{"id":"2468018355","title":"以岭药业:带头发展中药现代化,科技赋能传统医学","url":"https://stock-news.laohu8.com/highlight/detail?id=2468018355","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468018355?lang=zh_cn&edition=full","pubTime":"2024-09-17 19:22","pubTimestamp":1726572158,"startTime":"0","endTime":"0","summary":"以岭药业,作为中药行业的领航者,其独特的发展路径与卓越贡献在中药现代化与中医科学化的浪潮中熠熠生辉。此外,以岭药业在心血管领域同样成绩斐然,其多项循证医学研究项目已跻身国际顶级期刊,彰显了公司在中药创新研发方面的深厚底蕴与领先地位。截至目前,以岭药业已拥有14个专利中药品种,其中多个品种被纳入国家医保目录和基药目录,进一步巩固了其在中药市场的领先地位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://news.stockstar.com/IG2024091700006252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0046","BK0239","002603","BK0188","BK0042"],"gpt_icon":0},{"id":"2468606386","title":"科华生物新提交2件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2468606386","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468606386?lang=zh_cn&edition=full","pubTime":"2024-09-17 13:34","pubTimestamp":1726551263,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示,近日上海科华生物工程股份有限公司新提交2件商标注册申请。商标申请详情如下:今年以来上海科华生物工程股份有限公司新申请注册商标12件,截止目前公司共持有注册商标154件,另有12件商标尚在注册申请中。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091700003592.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0028","BK0188","002022"],"gpt_icon":0},{"id":"2467856475","title":"【机构调研记录】国联安基金调研乐鑫科技、上海莱士","url":"https://stock-news.laohu8.com/highlight/detail?id=2467856475","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467856475?lang=zh_cn&edition=full","pubTime":"2024-09-16 08:01","pubTimestamp":1726444904,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及9月13日披露的机构调研信息,国联安基金近期对2家上市公司进行了调研,相关名单如下:1)乐鑫科技 个股亮点:公司多年来深耕AIoT领域软硬件产品的研发与设计,专注于研发高集成、低功耗、性能卓越、安全稳定、高性价比的无线通信 MCU,现已发布ESP8266等系列芯片、模组和开发板,成为物联网应用的理想选择。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091600000233.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0196","BK0188","002252","688018","BK0028","BK0239","BK0231"],"gpt_icon":0},{"id":"2467607109","title":"鲁抗医药新提交1件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2467607109","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467607109?lang=zh_cn&edition=full","pubTime":"2024-09-15 13:30","pubTimestamp":1726378234,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示,近日山东鲁抗医药股份有限公司新提交1件商标注册申请。商标申请详情如下:今年以来山东鲁抗医药股份有限公司新申请注册商标1件,截止目前公司共持有注册商标230件,另有3件商标尚在注册申请中。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091500001380.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0046","600789","BK0239","BK0168"],"gpt_icon":0},{"id":"2467022863","title":"达安基因:市场对分子诊断试剂的需求量在增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2467022863","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467022863?lang=zh_cn&edition=full","pubTime":"2024-09-15 09:49","pubTimestamp":1726364959,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["002030","BK0028","BK0159","BK0042","BK0046","BK0168","BK0122","BK0188","BK0239"],"gpt_icon":0},{"id":"2467586680","title":"达安基因:9月13日接受机构调研,国海证券、广东凯鼎投资等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2467586680","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467586680?lang=zh_cn&edition=full","pubTime":"2024-09-14 09:58","pubTimestamp":1726279089,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年9月14日达安基因发布公告称公司于2024年9月13日接受机构调研,国海证券张沙、广东凯鼎投资甄义勇、佛山市松松投资丁新松、广东恒升基金管理罗煦娟、嘉亿资产陈超君、嘉强基金邓海茵 陈金峰、畅誉投资基金金美彤、广东燊茂私募基金李旭明、广州市思诺铂基金戎坚群、广东展麟私募基金黄日丰、广州市摩星岭控股温文俊、中财招商投资刘倩参与。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091400007112.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","000750","BK0159","BK0276","002030","BK0122","BK0042","BK0174","BK0188","BK0168","BK0183","BK0028","BK0239"],"gpt_icon":0},{"id":"2467031103","title":"天坛生物(600161)9月13日主力资金净卖出6911.55万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2467031103","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467031103?lang=zh_cn&edition=full","pubTime":"2024-09-14 08:20","pubTimestamp":1726273255,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年9月13日收盘,天坛生物报收于21.03元,下跌4.45%,换手率1.39%,成交量27.42万手,成交额5.81亿元。近5日资金流向一览见下表:天坛生物融资融券信息显示,融资方面,当日融资买入2862.64万元,融资偿还2340.17万元,融资净买入522.47万元,连续3日净买入累计1552.96万元。天坛生物主营业务:以健康人血浆、经特异免疫的健康人血浆为原材料和采用基因重组技术研发、生产血液制品,开展血液制品经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091400006709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0082","600161","BK0239","BK0168","BK0188","BK0046","BK0028","BK0185"],"gpt_icon":0},{"id":"2467039259","title":"健友股份:融资余额6670.15万元,创近一年新低(09-13)","url":"https://stock-news.laohu8.com/highlight/detail?id=2467039259","media":"东方财富","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467039259?lang=zh_cn&edition=full","pubTime":"2024-09-14 07:36","pubTimestamp":1726270560,"startTime":"0","endTime":"0","summary":"健友股份融资融券信息显示,2024年9月13日融资净偿还424.99万元;融资余额6670.15万元,创近一年新低,较前一日下降5.99%。融资方面,当日融资买入58.52万元,融资偿还483.51万元,融资净偿还424.99万元。融券方面,融券卖出2.22万股,融券偿还1.69万股,融券余量25.17万股,融券余额329.49万元。融资融券余额合计6999.63万元。健友股份融资融券交易明细(09-13)健友股份历史融资融券数据一览免责声明:本文基于AI生产,仅供参考,不构成任何投资建议,据此操作风险自担。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-09-14/doc-incpanuu5087982.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-09-14/doc-incpanuu5087982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0046","BK0186","603707","BK0239"],"gpt_icon":0},{"id":"2467717038","title":"上海莱士:有知名机构正心谷资本,高毅资产参与的多家机构于9月13日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2467717038","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467717038?lang=zh_cn&edition=full","pubTime":"2024-09-14 06:36","pubTimestamp":1726267019,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年9月13日上海莱士发布公告称东方证券资产管理马庆华、国联安基金褚乐延、博裕投资李嘉美、华福证券王宣宇 盛丽华、博时基金张之瑞、惠理基金冯雪云、中金公司全芳、银河证券程培 宋丽莹、正心谷资本谢博涛、高毅资产刘慧敏、国泰君安资管李子波于2024年9月13日调研我司。公司预计 2024 年全年将与基立福全球发生的日常关联交易金额约为 5.62 亿美元。该股最近90天内共有5家机构给出评级,买入评级5家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091400005459.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0196","BK0188","BK0028","002252","BK0239"],"gpt_icon":0}],"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"undefined(BK0046)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供undefined(BK0046)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":",BK0046,股票,股票老虎,股票老虎国际,行情,股票行情,股价,股市,股票价格,股票交易,股票购买,股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"undefined(BK0046)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供undefined(BK0046)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}